Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Navina does not list a price
Free plan
OpenEvidence
Only OpenEvidence has one
Higher rating
Tie
4.4 against 4.4
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Navina
OpenEvidence
Our rating
4.4
4.4
Starts at
Not listed
Free
Free plan
No
YesBetter
Category
Healthcare AI
Healthcare AI
Plans
See pricing
Free
Key features
Chart-prep summary that consolidates scattered records before a patient visit
Risk-adjustment and HCC coding gap detection built for value-based care contracts
Natural language processing that pulls relevant history out of unstructured notes and faxes
Quality-measure gap flagging tied to payer contract requirements
Integration layer that sits on top of existing EHR systems rather than replacing them
Point-of-care clinical answers grounded in peer-reviewed literature with citations
760,000 registered US physicians, roughly 40% of all US doctors
Approximately 18 million clinical consultations handled monthly
Free for verified physicians, monetized through pharmaceutical advertising
$12B valuation after a $250M Series D in January 2026
Pros
Backed by more than $100 million in funding including a Goldman Sachs-led round
Real deployment scale, about 10,000 clinicians across 1,300 clinics
Focused specifically on value-based care economics, not generic clinical documentation
Free access for physicians removes cost as a barrier to point-of-care use
Citations grounded in peer-reviewed literature build clinical trust
Extraordinarily fast physician adoption validates genuine day-to-day utility
Cons
Pricing is undisclosed and requires a sales cycle before a practice can evaluate cost
Built for value-based, risk-adjusted care models, a weaker fit for fee-for-service-only practices
Depends on clean data flow from a practice's existing EHR and fax or record sources
Monetized through pharmaceutical advertising, which some clinicians may view with caution
Built for point-of-care physician use, not a full clinical documentation platform
Extremely fast valuation growth invites scrutiny over long-term sustainability
Company
Navina, founded 2018
OpenEvidence, founded 2022
Prices come from each vendor's pricing page, last checked 20260718. Check the vendor before you buy.
FAQ
Questions people ask
Is Navina better than OpenEvidence?
In our reviews Navina scores 4.4 and OpenEvidence scores 4.4. The better pick depends on the job. Navina: AI copilot that organizes scattered patient records into actionable clinical insight for primary care physicians. OpenEvidence: Used by 40% of US physicians, doubling its valuation to $12B in under a year.
OpenEvidence
Navina
